Genotype-tailored Treatment of Symptomatic Acid-Reflux in Children With Uncontrolled Asthma (GenARA)
Sponsor: Jason Lang, M.D., M.P.H.
A PHASE3 clinical study on Asthma and Gastroesophageal Reflux, this trial is completed. The trial is conducted by Jason Lang, M.D., M.P.H. and has accumulated 15 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
15 versions recorded-
Oct 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Oct 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Jan 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Mar 2023 — Jan 2024 [monthly]
Recruiting PHASE3
▶ Show 10 earlier versions
-
Jun 2022 — Mar 2023 [monthly]
Recruiting PHASE3
-
Apr 2021 — Jun 2022 [monthly]
Recruiting PHASE3
-
Jan 2021 — Apr 2021 [monthly]
Recruiting PHASE3
-
Oct 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Mar 2020 — Oct 2020 [monthly]
Recruiting PHASE3
-
Mar 2019 — Mar 2020 [monthly]
Recruiting PHASE3
-
Jun 2018 — Mar 2019 [monthly]
Recruiting PHASE3
-
Feb 2018 — Jun 2018 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Aug 2017 — Feb 2018 [monthly]
Not Yet Recruiting PHASE3
-
Feb 2017 — Aug 2017 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Jason Lang, M.D., M.P.H.
- Nemours Children's Clinic
- Thrasher Research Fund
For direct contact, visit the study record on ClinicalTrials.gov .